ECBK
ECB Bancorp, Inc.
ECBK has the edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM
JPMorgan Chase & Co.
JPM has slightly lower modeled downside risk, despite its lower overall score.
ECBK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
ECBK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like ECBK.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
ECBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 14x | $20.45 | — |
| Cheap | 18x | $26.66 | +30% |
| Fair | 25x | $37.12 | +82% |
| Expensive | 39x | $58.32 | +185% |
Historical ranges are pointers, not guarantees.
ECBK has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
ECBK Forward outlook
There aren't enough analyst estimates for ECBK to show an outlook.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
ECBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.49 | +86% |
| Q2 2026 | $1.38 | +112% |
| Q1 2026 | $1.16 | +104% |
| Q4 2025 | $0.94 | +96% |
| Q3 2025 | $0.80 | +111% |
| Q2 2025 | $0.65 | +63% |
| Q1 2025 | $0.57 | +19% |
| Q4 2024 | $0.48 | -7.7% |
ECBK earned $1.49 per share over the past year, up 86% from the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
ECBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.1M | +26% |
| Q2 2026 | $10.3M | +29% |
| Q1 2026 | $10.2M | +47% |
| Q4 2025 | $9.5M | +34% |
| Q3 2025 | $8.8M | +33% |
| Q2 2025 | $8M | +27% |
| Q1 2025 | $6.9M | +11% |
| Q4 2024 | $7.1M | +15% |
ECBK has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 42% | +4.6 points |
| Q2 2026 | 43% | +19 points |
| Q1 2026 | 42% | +17 points |
| Q4 2025 | 37% | +9.4 points |
| Q3 2025 | 37% | +14 points |
| Q2 2025 | 24% | +7 points |
| Q1 2025 | 25% | +12 points |
| Q4 2024 | 27% | +10 points |
ECBK has the edge over JPM on profitability, with a higher operating margin.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
ECBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.4M | -13% |
| Q2 2026 | $11.8M | +538% |
| Q1 2026 | $2.8M | +$3.5M |
| Q4 2025 | $3.9M | -14% |
| Q3 2025 | $4M | +359% |
| Q2 2025 | $1.8M | +37% |
| Q1 2025 | -$649K | -$200K |
| Q4 2024 | $4.5M | +77% |
ECBK has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
ECBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +56.5K shares |
| 1 year | +1.4% | +119K shares |
| 3 years | -1.1% | -93.4K shares |
ECBK has 8M diluted shares, up 1.4% from a year ago, despite $2M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $188,000 |
| Q2 2026 | $675,000 |
| Q1 2026 | $350,000 |
| Q4 2025 | $513,000 |
| Q3 2025 | $2M |
| Q2 2025 | $1.5M |
| Q1 2025 | $673,000 |
| Q4 2024 | $902,000 |
ECBK spent $2M buying back its own shares over the past year, down 65% from the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over ECBK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
ECBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 16.3x | High |
| Q2 2026 | 17.9x | High |
| Q1 2026 | 19.5x | High |
| Q4 2025 | 26.3x | High |
| Q3 2025 | 28.1x | High |
| Q2 2025 | 34.9x | High |
| Q1 2025 | 35.0x | High |
| Q4 2024 | 40.2x | High |
ECBK's net debt is about 16 years of its operating earnings (EBITDA), down from more than 20 years a year ago. Net leverage isn't a meaningful measure for financial services companies like ECBK.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over ECBK on leverage, with a lower net debt burden relative to earnings.
ECBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.2 | Neutral |
| Stochastic | 56.6 | Neutral |
ECBK's weekly RSI is 52 (neutral) and its Stochastic is 57 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
ECBK PE vs Financial Services Sector
| Metric | ECBK | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 5.4% above |
| PE % | 0 | 58 | 58 pts below |
ECBK has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
ECBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.9 | 1.9% below |
| 20 week MA | $20.7 | 1.1% below |
| 50 week MA | $18.9 | 8% above |
| 100 week MA | $17.3 | 18% above |
| 200 week MA | $15.2 | 35% above |
ECBK has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 35% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over ECBK on trend strength, trading above more of its moving averages.
ECBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $14.0 | $16.1 | +15% |
| 2023 | $16.1 | $12.6 | -22% |
| 2024 | $12.6 | $14.9 | +19% |
| 2025 | $14.9 | $17.3 | +16% |
| 2026 YTD | $17.3 | $20.5 | +18% |
ECBK has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.